Importance of Incident-to Billing and Patient Access to NPP

importance of incident-to billing and patient access to NPP

United Healthcare (UHC) recently announced that they will reduce payment for NPP (Non-Physician Providers). This went into effect on May 1, 2021. However, this could potentially decrease patient access to care, especially if the reimbursement for NPP is at a reduced rate and physicians can no longer bill incident-to. We will explain the importance of incident-to billing and patient access to NPP.

Continue reading Importance of Incident-to Billing and Patient Access to NPP

The COVID-19 Vaccine: Pfizer Vaccine vs. Moderna Vaccine

Pfizer Vaccine vs. Moderna Vaccine for COVID-19

On December 18, 2020, the U.S. Food and Drug Administration (FDA) gave the emergency go-ahead for a second COVID-19 vaccine—developed by Moderna—to be provided to Americans across the country. Both the Pfizer and Moderna vaccines use the same basic technology, known as mRNA. Essentially, these vaccines teach your cells how to make protein that prompts an immune response without using the live virus that causes COVID-19. We will discuss the Pfizer vaccine vs. Moderna vaccine for COVID-19.

Continue reading The COVID-19 Vaccine: Pfizer Vaccine vs. Moderna Vaccine

PRP Therapy vs. Stem Cell Therapy for Psoriatic Arthritis

PRP Therapy vs. Stem Cell Therapy for Psoriatic Arthritis

Psoriatic Arthritis is an inflammatory condition of the joints associated with psoriasis. PRP therapy and stem cell therapy are two common treatment options for Psoriatic Arthritis. Therefore, we will discuss PRP therapy vs. stem cell therapy for Psoriatic Arthritis.

Continue reading PRP Therapy vs. Stem Cell Therapy for Psoriatic Arthritis

AOCBV is Particpating in the PrismRA Study for RA Biologic Therapy

PrismRA Study for RA Biologic Therapy

Imagine knowing if a treatment will work for you before you start taking it. Approximately 1 in 3 people who have Rheumatoid Arthritis (RA) who are prescribed a biologic (anti-TNF) therapy such as Humira, Enbrel, Remicade, Cimizia, Inflectra, Simponi or Simponi Aria will sufficiently respond to treatment. There is no tool currently available to predict which person will respond to these drugs. Scipher Medicine aspires to change this with PrismRATM, a new test that could improve how RA is treated. AOCBV is participating in this study to help change the way RA is treated.

Continue reading AOCBV is Particpating in the PrismRA Study for RA Biologic Therapy

When to See a Doctor for Back Pain?

when to see a doctor for back pain

It can be difficult to determine if you need to see a doctor or specialist for back pain, especially if you aren’t familiar with what a rheumatolgist is or what diseases they treat. A rheumatologist is a doctor who specializes in both musculoskeletal disorders and certain autoimmune diseases. AOCBV has a team of board-certified rheumatologists in Bryan/College Station, TX that are equipped to treat inflammatory back pain. We will discuss when to see a doctor for back pain.

Continue reading When to See a Doctor for Back Pain?